Anita Patel

Title: Professor
PhD, MSc, BSc
Professor of Health Economics

Anita Patel is a health economist. She joined the Centre for Primary Care and Public Health at Queen Mary University of London in February 2015 following 20 years at King’s College London. Her research has focused on establishing the cost-effectiveness of various health care treatments through applied multidisciplinary research, mostly within clinical trials (UK and international).

She has particular experience and expertise in evaluating complex interventions for people with long-term and difficult to manage conditions such as serious mental illness and stroke. Her work in these two clinical areas has been influential in underpinning national and international clinical guidelines and service change and she undertakes several external roles related to these areas.

She inputs to various taught and research degrees - at doctoral, masters and undergraduate levels - through teaching, supervision and assessment, and to short courses. She has also undertaken substantial roles related to monitoring and training for post-graduate research degrees, most recently as a theme leader for an ESRC-funded doctoral training centre.


Anita developed an interest in health economics as an undergraduate (BSc (Hons) Modular Studies (Economics), London Guildhall University, 1993) inspired by lecturer Richard Murray, whose good advice led her straight onto an MSc in Health Economics at the University of York (1994).

She then joined King’s College London as a Research Assistant in the Department of General Practice and Primary Care, working with Jeremy Dale and others to develop and evaluate computerised decision-support for handling advice-seeking telephone calls to primary care and hospital accident and emergency departments. This was followed by taking a new Health Economist role in the Community Division at King’s, to work alongside a public health specialist to promote and develop health economics and health services research across the division.

Whilst in that role, Anita received invaluable health economics supervision and support from Professor Martin Knapp and his colleagues at the Centre for the Economics of Mental Health (now King’s Health Economics) at the Institute of Psychiatry at King’s. She joined there as a Research Worker in 1998.

During her long stint there, Anita went on to hold positions of Lecturer/Senior Lecturer/Reader/Co-Deputy Director, completed a part-time PhD (“Issues in multi-national health economic evaluation” 2006) and had three children. She now retains a link as a Visiting Professor whilst continuing with ongoing projects and student supervisions there.


Anita’s position of Chair in Health Economics was created to lead the development of health economics within the Centre for Primary Care and Public Health, through two major roles:

  • Lead health economist for the Pragmatic Clinical Trials Unit, providing economic expertise on the design and conduct of economic evaluations for new and ongoing studies.
  • Leading the health economics research agenda for the prestigious Asthma UK Centre for Applied Research (AUK-CAR), a UK-wide 13-university multidisciplinary collaboration jointly led by the University of Edinburgh and Queen Mary University of London.

Prior to joining QMUL, Anita was a named co-applicant/co-investigator on collaborative research awards totalling £19m from the National Institute for Health Research, European Commission, Medical Research Council, King’s Fund, pharmaceutical companies and other funders. She also undertook key economics-related roles in securing and/or delivering a further £17m of research. A major role from 2011-15 was co-applicant and economic lead for an external assessment centre funded by the National Institute for Health and Care Excellence (NICE) to support its decision-making on NHS adoption of innovative medical technologies.

Other current or recent research projects include:

  • LOCAPE: Location of care for people with serious mental illness: implications for service use and costs (Paul McCrone, National Institute for Health Research HS&DR)
  • EMERALD: Emerging mental health systems in low- and middle-income countries (Graham Thornicroft, European Commission 7th Framework Programme)
  • INTERFACE: Enhancing the Multi-Agency Management of Individuals with Enduring Moderate to Severe Mental Health Needs: Client Journeys and the NHS/CJS Interface (Susan Lea, National Institute for Health Research SDO)
  • STROKE-INF: A randomised controlled trial of different strategies of antibiotic use to reduce the incidence and consequences of chest infection in acute stroke patients with swallowing problems (Lalit Kalra, National Institute for Health Research RfPB)
  • TACIT: Randomised controlled trial of tumour-necrosis-factor inhibitors against combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: the TACIT trial (David Scott, National Institute for Health Research HTA)
  • IMPACT: Improving Physical Health and reducing substance use in severe mental illness (Robin Murray & Fiona Gaughran, National Institute for Health Research PGfAR)
  • SOUL-D/D6: Non-pharmacological approaches to improving diabetes outcomes (Stephanie Amiel, National Institute for Health Research PGfAR)
  • LoTSCare: Improving patient and carer centred outcomes in longer-term stroke care (Anne Forster, National Institute for Health Research PGfAR)


Forster A, Dickerson J, Young J, Patel A, Kalra L, Nixon J, Smithard D, Knapp M, Holloway I, Anwar S, Farrin A on behalf of the TRACS Trial Collaboration. A cluster randomised controlled trial and cost–effectiveness analysis of a structured training programme for caregivers of in-patients after stroke (TRACS). Lancet 2013; 382 (9910): 2069-2076.

Patel A, McCrone P, Leese M, Amaddeo F, Tansella M, Kilian R, Angermeyer M, Kikkert M, Schene A Knapp M. Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countries. Cost Effectiveness and Resource Allocation 2013; 11: 12

Knapp M, Patel A, Curran C, Latimer E, Burns B, Catty J, Becker T, Drake RE, Fioritti A, Lauber C, Rössler W, Tomov T, van Busschbach J, White S, Wiersma D. Supported employment: cost-effective and cost-saving across six European sites. World Psychiatry 2013; 12 (1): 60-68.

McCrone P, Dhanasiri S, Patel A, Knapp M, Lawton-Smith S. Paying the price: the cost of mental health care in England to 2026. The King’s Fund, London, May 2008. ISBN 978 1 85717 571 4.

McCrone P, Patel A, Knapp M, Schene A, Koeter M, Amaddeo F, Ruggeri M, Giessler A, Puschner B, Thornicroft G. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. Journal of Mental Health Policy and Economics 2009; 12: 27-31.

Hurley MV, Walsh NE, Mitchell HL, Pimm J, Williamson E, Jones RH, Reeves BC, Dieppe PA, Patel A. Economic evaluation of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain. Arthritis & Rheumatism (Arthritis Care & Research) 2007; 57 (7): 1220-1229.

Patel A. Guest editorial: Conducting and interpreting multi-national economic evaluations: the measurement of costs. In: Curtis L & Netten A. Unit Costs of Health and Social Care, PSSRU, University of Kent, 2006.

Patel A, Everitt B, Knapp M, Reeder C, Grant D, Ecker C, Wykes T. Schizophrenia patients with cognitive deficits: factors associated with costs. Schizophrenia Bulletin 2006; 32: 766-785.

Patel A, Rendu A, Moran P, Leese M, Mann A, Knapp M. A comparison of two methods of collecting economic data in primary care. Family Practice 2005 22(3): 323-327.

Patel A, Knapp M, Evans A, Perez I, Kalra L. Training care givers of stroke patients: economic evaluation. BMJ 2004; 328: 1102-1104.

Patel A, Knapp M, Perez I, Evans A, Kalra L. Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial. Stroke 2004; 35 (1): 196-203.

View all Anita Patel 's Research Publications at:


Teaching and assessment for the Introduction to Health Economics module of the QMUL BSc in Global Health

Assessment for the QMUL MSc in Global Public Health & Policy

Teaching for the QMUL MSc in Dental Public Health

Tutor and facilitator for the QMUL MBBS programme

Short courses delivered by the QMUL Pragmatic Clinical Trials Unit

Host and supervisor to students conducting dissertations on placement from health economics masters courses delivered by other UK universities

PhD second supervisor to Jan Wolff (King’s College London): Patient-specific resource intensity of inpatient mental health care (2012-2018)

PhD second supervisor to Wayne Smith (King’s College London): Development of a preference based outcome measure for use in economic evaluations in mental health (2013-2016)

Further information

Current external roles:

Visiting Professor, King’s Health Economics, King’s College London

Member, Royal College of Physicians Intercollegiate Stroke Working Party

Member, Stroke Association Research Awards Pool

Member, Expert panel on stroke, Research Agenda for Health Economic Evaluation (RAHEE) project, World Health Organization Representation to the European Union

Member, Steering Committee, ‘Innovations in major system reconfiguration in England: a study of the effectiveness, acceptability and processes of implementation of two models of stroke care’, Naomi Fulop, National Institute for Health Research HS&DR

Peer reviewer, various national and international journals and national funding bodies


020 7882 6031
This email address is being protected from spambots. You need JavaScript enabled to view it.